tradingkey.logo

Avidity Biosciences Ord Shs

RNAM
72.860
0.0000.00%
Close 03/03, 16:00ETQuotes delayed by 15 min
--Market Cap
--P/E TTM

Avidity Biosciences Ord Shs

72.860
0.0000.00%

More Details of Company

Avidity Biosciences Ord Shs Info

Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -

Company Executives of Avidity Biosciences Ord Shs

Name
Name/Position
Position
Shareholding
Change
Dr. Troy E. Wilson, J.D., Ph.D.
Dr. Troy E. Wilson, J.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Arthur A. Levin, Ph.D.
Dr. Arthur A. Levin, Ph.D.
Distinguished Scientist and Strategic Leader, Director
Distinguished Scientist and Strategic Leader, Director
--
--
Ms. Sarah Boyce
Ms. Sarah Boyce
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Michael F. (Mike) Maclean
Mr. Michael F. (Mike) Maclean
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Carsten Boess
Mr. Carsten Boess
Independent Director
Independent Director
--
--
Dr. Noreen Roth Henig, M.D.
Dr. Noreen Roth Henig, M.D.
Independent Director
Independent Director
--
--
Dr. Edward M. (Ed) Kaye, M.D.
Dr. Edward M. (Ed) Kaye, M.D.
Independent Director
Independent Director
--
--
Ms. Tamar Thompson
Ms. Tamar Thompson
Independent Director
Independent Director
--
--
Ms. Jean Kim
Ms. Jean Kim
Independent Director
Independent Director
--
--
Dr. W. Michael Flanagan, Ph.D.
Dr. W. Michael Flanagan, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Troy E. Wilson, J.D., Ph.D.
Dr. Troy E. Wilson, J.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Arthur A. Levin, Ph.D.
Dr. Arthur A. Levin, Ph.D.
Distinguished Scientist and Strategic Leader, Director
Distinguished Scientist and Strategic Leader, Director
--
--
Ms. Sarah Boyce
Ms. Sarah Boyce
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Michael F. (Mike) Maclean
Mr. Michael F. (Mike) Maclean
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Carsten Boess
Mr. Carsten Boess
Independent Director
Independent Director
--
--
Dr. Noreen Roth Henig, M.D.
Dr. Noreen Roth Henig, M.D.
Independent Director
Independent Director
--
--

Revenue Breakdown

FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2022
FY2021
FY2020
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%

Institutional Shareholding

Relevant data have not been disclosed by the company yet.
Reporting Period
No. of institutions
Shares Held
Proportion
Change
No Data

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
No Data

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI